Evaluation of 3TC or FTC Monotherapy Compared to Continuing HAART as a Bridging Antiretroviral Strategy in Persistently Non-adherent Children, Adolescents, and Young Adults Who Are Failing HAART and Have the M184V Resistance Mutation.
Phase of Trial: Phase IV
Latest Information Update: 18 Nov 2015
At a glance
- Drugs Emtricitabine (Primary) ; Lamivudine (Primary) ; Antiretrovirals
- Indications HIV infections
- Focus Therapeutic Use
- 24 Jun 2013 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 28 Jan 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 05 Sep 2012 Primary endpoint amended as reported by ClinicalTrials.gov.